Skip to main content
SpringerLink
Log in

Die japanische Pharmaindustrie

  • Chapter
Japans Zukunftsindustrien

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alexander DL, Flynn JE, Linkins LA (1995) Innovation, R&D Productivity, and Global Market Share in the Pharmaceutical Industry. Review of Industrial Organization 10: 197–207

    Article  Google Scholar 

  • Akaho E, Fuji M, Inoue K, Hosono K, Bernan P, Gudorf P, Huang XJ (1995) A Comparative Study of Pricing and Marketing of Drugs Acting on the Central Nervous System in the U.S., Japan, and Quebec, with a Search for Factors to Stimulate Research and Development Activities. Journal of Research in Pharmaceutical Economics 6(4): 29–55

    Google Scholar 

  • Chabala JC (1998) Historical Overview of the Developing Field of Molecular Diversity. In: Gordon EM, Kerwin JF Jr. (Hrsg) Combinatorial Chemistry and Molecular Diversity in Drug Discovery. New York, S 3–16

    Google Scholar 

  • DiMasi JA, Hansen RW, Grabowski HG (2002) The Price of Innovation: New Estimates of Drug Development Costs. Journal of Health Economics 22: 151–185

    Article  Google Scholar 

  • EFPIA European Federation of Pharmaceutical Industries and Associations (2002) The European Pharmaceutical Industry-Key Data. Brüssel

    Google Scholar 

  • FDA Federal Food and Drug Administration (2004) NCE approved 1998–2004. Http://www.fda.org (Zugriff am 01.10.2004)

    Google Scholar 

  • Gambardella A, Orsenigo L, Pamolli F (2000) Global Competetiveness in Pharmaceuticals. Europäische Kommission, Brüssel

    Google Scholar 

  • Grabowski H, Vernon J, DiMasi J (2003) Returns on Research and Development for 1990’s New Drug Introductions. PharmacoEconomics 20(3): 11–29

    Article  Google Scholar 

  • Granstrand O (1999) Internationalization of Corporate R&D: A Study of Japanese and Swedish Corporations. Research Policy 28: 275–302

    Article  Google Scholar 

  • Halliday RG (1996) Success in Pharmaceutical R&D: The Different Strategies of Western and Japanese Companies. Drug Information Journal 30: 821–838

    Google Scholar 

  • Hawkins ES, Reich MR (1992) Japanese-Originated Pharmaceutical Products in the United States from 1960 to 1989: An Assessment of Innovation. Clinical Pharmacology & Therapeutics 51(1): 1–11

    Article  Google Scholar 

  • Henderson R, Cockburn I (1996) Scale, Scope and Spillovers: The Determinants of Research and Productivity in the Drug Industry. RAND Journal of Economics 27: 32–59

    Article  Google Scholar 

  • Hisashige A (1997) Healthcare Technology Assessment and the Challenge to Pharmaeconomics in Japan. PharmacoEconomics 11(4): 319–333

    Google Scholar 

  • Huttin C (1995) The Japanese Drug Price Policy: A New Dynamic of Price Competition. Journal of Research in Pharmaceutical Economics 6(2): 21–34

    Google Scholar 

  • Ikeda S, Ikegami N, Gudorf P, Olivier AJ, Ikeda M (1996) A Case for the Adoption of Pharmacoeconomic Guidelines in Japan. PharmacoEconomics 10(6): 546–551

    Google Scholar 

  • Ikegami N, Mitchell W, Penner-Hahn J (1994) Pharmaceutical Prices, Quantities and Innovation. PharmacoEconomics 6(5): 424–433

    Google Scholar 

  • IMS Health (2001) Pharma-Prognosis International, 2001–2005. Fairfield

    Google Scholar 

  • JPA Japan Pharmaceutical Association (2004) Annual Report. TŌkyŌ

    Google Scholar 

  • JETRO (1992) Your Market in Japan — Pharmaceuticals. Tokio (3. Aufl.)

    Google Scholar 

  • JPMA Japan Pharmaceutical Manufacturers Association (2002) Pharmaceutical Administration and Regulations in Japan. Tokio

    Google Scholar 

  • JPMA (2003) Data Book 2002. Tokio

    Google Scholar 

  • Kiba T (1996) A Study of the Performance of the Japanese Companies’ Overseas-based R&D. NISTEP Report 43

    Google Scholar 

  • Kiba T, Collison S (1998) R&D Performance in Japanese Companies: A Relative Evaluation of Overseas-Based and Domestic R&D. Science and Public Policy 25(4): 227–238

    Google Scholar 

  • Kneller R (2003) Autarkic Drug Discovery in Japanese Pharmaceutical Companies: Insights into National Differences in Industrial Innovation. Research Policy 32: 1805–1827

    Article  Google Scholar 

  • Lahana R (1997) Virtuelle kombinatorsiche Chemie. Spektrum der Wissenschaft 6: 35–37

    Google Scholar 

  • Mahlich J (2002) Probleme und Perspektiven der japanischen Pharmaindustrie. In: Pohl M, Wieczorek I (Hrsg) Japan 2001/2002 — Politik und Wirtschaft. Deutsches Institut für Asienkunde, Hamburg, S 184–208

    Google Scholar 

  • Mahlich J (2003) Das japanische Innovationssystem im Überblick. In: Pohl M, Wieczorek I (Hrsg) Japan 2003 — Politik und Wirtschaft. Deutsches Institut für Asienkunde, Hamburg, S 193–221

    Google Scholar 

  • Mahlich J (2004) Neue Entwicklungen in den Banken-Firmen Beziehungen in Japan. In: Pohl M, Wieczorek I (Hrsg) Japan 2004 — Politik und Wirtschaft. Deutsches Institut für Asienkunde, Hamburg, S 243–264

    Google Scholar 

  • McLellan M (1997) A turning point in Japanese sales promotion. Scrip Magazine 10: 25–27

    Google Scholar 

  • MHLW Ministry of Health, Labor and Welfare (2002) To Reinforce the Global Competitiveness of the Pharmaceutical Industry, Mainstay of the “Century of Life”—Vision of the Industry. Tokio

    Google Scholar 

  • MOF Ministry of Finance (2005) Budget Program by Function. Tokio

    Google Scholar 

  • Morgan Stanley Dean Witter (1998) Japan Investment Research: Japan Pharmaceuticals. Tokio

    Google Scholar 

  • Morioka J (2004) An Overview of the US Drug Development Strategies of Japanese Pharmaceutical Companies. Business Briefing: PharmaTech 6: 1–6

    Google Scholar 

  • Odagiri H, Yamawaki H (1986) A Study of Company Profit Rates Time Series — Japan and the United States. International Journal of Industrial Organization 4: 1–23

    Article  Google Scholar 

  • Ohmichi H (1994) Current Pharmacoeconomic Issues in Japanese Healthcare. PharmacoEconomics 6(3): 193–195

    Google Scholar 

  • OECD (2004) Health Data. Paris

    Google Scholar 

  • Okada Y, Kawara A (2004) Research Productivity in the Japanese Pharmaceutical Industry-Economies of Scale, Economies of Scope and Spillovers. Hitosubashi University, Working Paper

    Google Scholar 

  • PhRMA Pharmaceutical Research and Manufacturers of America (1999) 1998 Industry Profile. Washington DC

    Google Scholar 

  • PhRMA (2004) 2003 Industry Profile. Washington DC

    Google Scholar 

  • Sharp M, Patel P, Pavitt K (1996) Europe’s Pharmaceutical Industry: An Innovation Profile. EIMS 32

    Google Scholar 

  • Seo T (1994) Prescribing and Dispensing of Pharmaceuticals in Japan. PharmacoEconomics 6(2): 95–102

    Google Scholar 

  • Sigurdson J (1996) Future Advantage Japan? London

    Google Scholar 

  • Thomas LG (1994) Pricing, Regulation, and Competitiveness: Lessons for the US from the Japanese Pharmaceutical Industry. PharmacoEconomics 6(Suppl. 1): 67–70

    Article  Google Scholar 

  • Thomas LG (2001) The Japanese pharmaceutical industry: The new drug lag and the failure of industrial policy. Cheltenham

    Google Scholar 

  • VFA Verband forschender Arzneimittelhersteller (2003) Die Arzneimittelindustrie in Deutschland. Berlin

    Google Scholar 

  • Wood Mackenzie (2004) PharmaQuant® Plus Overview. Edinburgh

    Google Scholar 

  • Yamamoto Y (1997) Ministry continues drug price cuts; foreign firms make in-roads. Japan Economic Almanac: 98–99

    Google Scholar 

Download references

Authors
  1. Jörg Mahlich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. DIJ - German Institute for Japanese Studies, Nissei kojimachi Bldg. 2F. Kudan Minami 3-3-6 Chiyoda-ku, 102-0074, Tokyo, Japan

    Andreas Moerke

  2. Institut für Asienkunde, Rothenbaumchaussee 32, D-20148, Hamburg, Germany

    Anja Walke

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mahlich, J. (2007). Die japanische Pharmaindustrie. In: Moerke, A., Walke, A. (eds) Japans Zukunftsindustrien. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29808-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-29808-3_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-29806-9

  • Online ISBN: 978-3-540-29808-3

  • eBook Packages: Business and Economics (German Language)

Publish with us

Policies and ethics

Search

Navigation